8T5P image
Deposition Date 2023-06-14
Release Date 2023-11-29
Last Version Date 2023-12-06
Entry Detail
PDB ID:
8T5P
Title:
SARS-CoV-2 ORF3a peptide in complex with TRAF3 TRAF domain
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:TNF receptor-associated factor 3
Gene (Uniprot):TRAF3
Chain IDs:A, B, C, D, E, F
Chain Length:192
Number of Molecules:6
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:ORF3a protein
Gene (Uniprot):3a
Chain IDs:G, H, I
Chain Length:5
Number of Molecules:3
Biological Source:Severe acute respiratory syndrome coronavirus 2
Primary Citation
SARS-CoV-2 ORF3a-Mediated NF-kappa B Activation Is Not Dependent on TRAF-Binding Sequence.
Viruses 15 ? ? (2023)
PMID: 38005906 DOI: 10.3390/v15112229

Abstact

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a global pandemic of Coronavirus Disease 2019 (COVID-19). Excessive inflammation is a hallmark of severe COVID-19, and several proteins encoded in the SARS-CoV-2 genome are capable of stimulating inflammatory pathways. Among these, the accessory protein open reading frame 3a (ORF3a) has been implicated in COVID-19 pathology. Here we investigated the roles of ORF3a in binding to TNF receptor-associated factor (TRAF) proteins and inducing nuclear factor kappa B (NF-κB) activation. X-ray crystallography and a fluorescence polarization assay revealed low-affinity binding between an ORF3a N-terminal peptide and TRAFs, and a dual-luciferase assay demonstrated NF-κB activation by ORF3a. Nonetheless, mutation of the N-terminal TRAF-binding sequence PIQAS in ORF3a did not significantly diminish NF-κB activation in our assay. Our results thus suggest that the SARS-CoV-2 protein may activate NF-κB through alternative mechanisms.

Legend

Protein

Chemical

Disease

Primary Citation of related structures